Biomarker commercialisation project approved


The goal of the project is to increase the commercial potential of biomarker discoveries in the Baltic Sea Region

Biomarker commercialisation project approved

Ideklinikken at Aalborg University Hospital, the University of Turku, Finland, The University of Vilnius, Lithuania, and the 6 innovation clusters Biopeople (Denmark), BioCon Valley (Germany), Turku Science Park (Finland), Tartu Biotechnology Park (Estonia), Wroclaw Technology Park (Poland) and ScanBalt covering the Baltic Sea Region earlier this year applied for an interregional project related to the commercialisation of biomarkers (BiC). The project will create and stimulate synergies between industry, cluster organisations and research institutions across the Baltic Sea Region.

“The project consortium intend to involve industry earlier in the development and commercialization process of biomarkers and develop tools providing guidance to research institutions when selecting the most relevant biomarker discoveries and conduct a development plan that meets early requirements from industry,” says Kjeld Lisbye, Head of Innovation in the Northern Region of Denmark. “We want to define the downstream pathway from research, validation, development to the market, co-created with industry in order to speed up the process and create successful spinouts.”

The BiC project will focus on the development of the below tools which will be available via Scanbalt Business Club beyond the project period:

  • a Biomarker Development Tool
  • a Screening and Selection Guide
  • a Framework for Technology Translation into clinical setting
  • Business Model Templates
  • BSR Biomarker Platform, Technology presentation and match making tools

Latest news

Overwhelming interest from leading speakers in First Nordic conference on personalized medicine11-04-2018
The conference in Nyborg looks mainly at the underlying mechanisms causing variability in clinical response and drug toxicity. We talked to organizer...
Cancer therapies: How we link drug sensitivity to molecular profiling to identify biomarkers23-03-2018
Professor Krister Wennerberg talks on stratified cancer therapies and their predictive biomarkers at the Oncology Network meeting April 9th.
Biopeople i nyt samarbejde med magasinet Life Science22-03-2018
I 2018 har Biopeople indgået et samarbejde med bladet Life Science – Dansk Biotek (in Danish only).
Call: USA East Coast Innovation Tour - Greater Boston & Greater New York - deadline March 30th21-03-2018
The Innovation Tour is specifically focused on life science companies from Europe to explore research, commercialization and investment opportunities...
Internationalt uddannelsessamarbejde inden for regulering af medicin20-03-2018
Den 27. februar 2018 arrangerede Biopeople og Copenhagen Centre for Regulatory Science en international workshop for mere end 25 unge forskere fra...


What are you looking for?
This site uses the functionality that older versions of Internet Explorer does not support. You should therefore switch or upgrade your browser.